AI Science Tracker
EN

Machine learning identifies PPARG as a diagnostic biomarker for sepsis linked to CD14/NF-κB signaling: integrated transcriptomics and experimental validation.

Department of Critical Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China · 28 May 2026 · medicine

Discovery

Machine learning identifies PPARG as a diagnostic biomarker for sepsis linked to CD14/NF-κB signaling: integrated transcriptomics and experimental validation.

Source check: Source checked. Not independent scientific confirmation.

Finding: Transcriptomic machine-learning analysis identified PPARG as a candidate diagnostic biomarker for sepsis; the study reports experimental follow-up of the candidate and its CD14/NF-κB signaling context. This does not establish clinical diagnostic utility.

Technology: Machine-learning transcriptomic analysis identifies PPARG as a sepsis biomarker candidate for experimental follow-up.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Machine-learning transcriptomic analysis identifies PPARG as a sepsis biomarker candidate for experimental follow-up.
Test and result
Experimental follow-up was reported, but clinical diagnostic utility and prospective performance were not established.
Limitation / still unknown
External replication and real-world or clinical benefit were not established by the reviewed study
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC13253277/ · https://pubmed.ncbi.nlm.nih.gov/42291298/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.